Report 26 Jan 2012

Fact sheet 4: Benefits of healthcare worker immunization

Read more
Report 26 Jan 2012

Fact sheet 3: Economic benefits of immunization

Read more
Report 26 Jan 2012

Fact sheet 2: Influenza risk groups

Read more
Report 26 Jan 2012

Fact sheet 1: Public health benefits of immunization

Read more
Report 26 Jan 2012

Improving global health through pharmaceutical innovation

Read more
Report 26 Jan 2012

IFPMA code of practice (2012)

Read more
Report 26 Jan 2012

Ending neglected tropical diseases 2012 IFPMA member companies support eliminating and controlling neglected tropical diseases over the next decade through landmark donations

Read more
Statement 20 Jan 2012

Agenda item 6.11, “Elimination of schistosomiasis” at the 130th Executive Board of the World Health Organization

130th Executive Board of the World Health Organization  IFPMA Statement under agenda item 6.11, “Elimination of Schistomiasis” Remarks by Mario Ottiglio, Associate Director, Global Health Policy and Public Affairs Mr. Chairman, Madam Director General, distinguished members of the Executive Board, Excellencies, ladies and gentlemen, Thank you for the opportunity to input on the important discussions...

Read more
Video 5 Jan 2012

Video Part 1 by Tim Wilsdon, Charles River Associates

IFPMA Geneva Pharma Forum: Access to antiretrovirals in developing countries: towards a new landscape?

Read more
Video 5 Jan 2012

Video Part 2 by Tim Wilsdon, Charles River Associates

IFPMA Geneva Pharma Forum: Access to antiretrovirals in developing countries: towards a new landscape?

Read more
Video 5 Jan 2012

Video Part 3 by Tim Wilsdon, Charles River Associates

IFPMA Geneva Pharma Forum: Access to antiretrovirals in developing countries: towards a new landscape?

Read more
Video 5 Jan 2012

Video Part 4 by Tim Wilsdon, Charles River Associates

IFPMA Geneva Pharma Forum: Access to antiretrovirals in developing countries: towards a new landscape?

Read more